This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cedars-Sinai investigators are using AI to analyze images from a common heart test to identify signs of valve disease. By applying AI to echocardiograms, we can help clinicians more easily detect the signs of heartvalve disease so that patients get the care they need as soon as possible. Photo: Getty.
The meeting will take place September 12-13, 2025, in Seoul, Korea. KTCVS-STS Asia Symposium on Valvular Heart Disease Adult Cardiac Resident / Fellow Surgeon Asia Image Details will be added here as they become available.
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heartvalve surgery.
Dr. Shettys team followed 252 patients who underwent the Ross procedure, a heartvalve replacement operation commonly used to treat younger patients with severe aortic valve disease. In fact, most of our patients are not on any cardiac medications following one year after surgery.
tim.hodson Tue, 02/18/2025 - 16:41 Feb. tim.hodson Tue, 02/18/2025 - 16:41 Feb. Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heartvalve disease is expected to double by 2040 and triple by 2060.As The Association receives funding primarily from individuals.
17, 2025 DALLAS, Feb. 17, 2025 The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome measures. Embargoed until 4:00 a.m. CT/5:00 a.m. ET Monday, Feb.
tim.hodson Mon, 03/17/2025 - 14:56 March 17, 2025 Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Associations flagship journal Circulation. are forms of congenital heart defects (CHD).
In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. tim.hodson Tue, 02/18/2025 - 10:08 Feb. How has treatment for tricuspid valve disease evolved? Image by Getty.
We are pleased to announce that the BJC is in partnership with Cardiac Risk in the Young (CRY), we have a new forthcoming series on sports cardiology, and a statement from The British HeartValve Society.
22, 2025 More than 60,000 people die from heartvalve disease (HVD) in the U.S. each year, according to the American Heart Association 2025Heart Disease and Stroke Statistical Update. DALLAS, Feb. Additionally, data from the Statistical Update shows.
tim.hodson Tue, 03/04/2025 - 14:11 Feb. 22, 2025More than 60,000 people die from heartvalve disease (HVD) in the U.S. each year, according to the American Heart Association 2025Heart Disease and Stroke Statistical Update. This year on HeartValve Disease Awareness Day (Feb.
As the pioneer in valve innovation for more than 60 years, Edwards believes it is uniquely positioned to lead this next frontier of aortic valve disease treatment. Edwards anticipates FDA approval of the JenaValve Trilogy HeartValve System in late 2025, which will represent the first approved therapy for patients suffering from AR.
Stroke, Volume 56, Issue Suppl_1 , Page ATP4-ATP4, February 1, 2025. The NOAC exclusion group were more likely to have medical co-morbidities including Afib/Aflutter, prosthetic heartvalves, CAD/prior MI, heart failure, prior DVT/PE and sleep apnea (Table 1).
In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. tim.hodson Tue, 02/18/2025 - 10:08 Feb. How has treatment for tricuspid valve disease evolved? Image by Getty.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content